Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAM: Apixaban and Dexamethasone Interaction in Multiple Myeloma
NCT02749617Phase 2Terminated
- Sponsor
- University of British Columbia
- Start
- Aug 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in venous thromboembolism (VTE), sponsored by University of British Columbia. Started Aug 2016; status: terminated.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02749617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749617.